Review of rivastigmine and its clinical applications in Alzheimer's disease and related disorders.
about
Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neuronsMethods to improve the detection of mild cognitive impairmentRivastigmine for subcortical vascular dementia.Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease.Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
P2860
Review of rivastigmine and its clinical applications in Alzheimer's disease and related disorders.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Review of rivastigmine and its ...... disease and related disorders.
@ast
Review of rivastigmine and its ...... disease and related disorders.
@en
Review of rivastigmine and its ...... disease and related disorders.
@nl
type
label
Review of rivastigmine and its ...... disease and related disorders.
@ast
Review of rivastigmine and its ...... disease and related disorders.
@en
Review of rivastigmine and its ...... disease and related disorders.
@nl
prefLabel
Review of rivastigmine and its ...... disease and related disorders.
@ast
Review of rivastigmine and its ...... disease and related disorders.
@en
Review of rivastigmine and its ...... disease and related disorders.
@nl
P2860
P356
P1476
Review of rivastigmine and its ...... disease and related disorders.
@en
P2093
P2860
P304
P356
10.1517/14656566.2.4.653
P407
P577
2001-04-01T00:00:00Z